Cargando…
How to handle oligometastatic disease in nonsmall cell lung cancer
Patients with nonsmall cell lung cancer and limited metastatic disease have been defined as oligometastatic if local ablative therapy of all lesions is amenable. Evidence from different clinical retrospective series suggests that this subgroup harbours better prognosis than other stage IV patients....
Autores principales: | Eichhorn, Florian, Winter, Hauke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488336/ https://www.ncbi.nlm.nih.gov/pubmed/33650527 http://dx.doi.org/10.1183/16000617.0234-2020 |
Ejemplares similares
-
Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
por: Gomez, Daniel R., et al.
Publicado: (2012) -
Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017) -
Bronchoscopic treatment of inoperable nonsmall cell lung cancer
por: Kniese, Christopher M., et al.
Publicado: (2020) -
New developments in locally advanced nonsmall cell lung cancer
por: Huber, Rudolf M., et al.
Publicado: (2021) -
Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer
por: Abdayem, Pamela, et al.
Publicado: (2021)